CivicaScript LLC, a nonprofit focused on bringing low-cost generic medicines to US patients, announced on Thursday that it has launched its droxidopa in the United States.

Droxidopa is intended for the treatment in adults of certain types of orthostatic dizziness, light-headedness or the 'feeling that you are about to black out'.

The company will be providing droxidopa 300mg capsules for sale to pharmacies from 10 April, priced at USD132 per bottle of 90 capsules. It has been recommended that pharmacies charge patients no more than USD153 per bottle.

CivicaScript will offer 100 mg, 200 mg and 300 mg strengths of droxidopa capsules.